Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited Operating Income for the year ending March 31, 2024: USD 1.22 M

Medico Remedies Limited Operating Income is USD 1.22 M for the year ending March 31, 2024, a 45.16% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Medico Remedies Limited Operating Income for the year ending March 31, 2023 was USD 839.60 K, a 23.66% change year over year.
Medico Remedies Limited Operating Income for the year ending March 31, 2022 was USD 678.95 K, a 38.48% change year over year.
Medico Remedies Limited Operating Income for the year ending March 31, 2021 was USD 490.29 K, a 211.35% change year over year.
Medico Remedies Limited Operating Income for the year ending March 31, 2020 was USD 157.47 K, a -12.59% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years